UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 14, 2006
ANGIOGENEX, INC.
------------------------------------------------
(Name of Small Business Issuer in its Charter)
Nevada 000-26181 86-0945116
---------------------------- ------------ ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
425 Madison Ave., Ste. 902, New York, NY 10025
--------------------------------------------------------------------
(Address of principal executive offices)
(212) 874-6608
---------------------------
(Issuer's telephone number)
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
===============================================================================
1
Item 8.01 Other Events.
On December 14, 2006, the Company received clearance from the NASD for
quotation on the Over-The-Counter Bulletin Board ("OTCBB"). The Company's
stock will trade under the symbol AGGX.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AngioGenex, Inc.
-----------------------
Registrant
By: /s/ Martin Murray
------------------------------------
Name: Martin Murray
Title: Chief Financial Officer
Dated: December 18, 2006
2